Spinal muscular atrophy (SMA) patient survey: Impact of Risdiplam on the SMA patients
By Katie Nevin, Clinical specialist physiotherapist in neuromuscular disorders, Sheffield Teaching Hospitals NHS Foundation Trust
Project poster
Project write up
More Neuromuscular Academy Medication Projects
Improving the process of securing intravenous access in patients receiving Zolgensma
By Emma Kimpton, Susan George & Toni Lawford, Sheffield Children's NHS Foundation Trust
Spinal muscular atrophy (SMA) patient survey: Impact of Risdiplam on the SMA patients
By Katie Nevin, Clinical specialist physiotherapist in neuromuscular disorders, Sheffield Teaching Hospitals NHS Foundation Trust
Raising awareness, improving outcomes
Neuromuscular Academy is the first bespoke course for healthcare professionals to receive expert training in neuromuscular conditions like spinal muscular atrophy.